- Home
- Publications
- Publication Search
- Publication Details
Title
Future treatment of patients with HCV cirrhosis
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 32, Issue -, Pages 113-119
Publisher
Wiley
Online
2011-12-30
DOI
10.1111/j.1478-3231.2011.02702.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003–2007)
- (2011) Marc Bourlière et al. ANTIVIRAL THERAPY
- A review of the treatment of chronic hepatitis C virus infection in cirrhosis
- (2011) Elena Vezali et al. CLINICAL THERAPEUTICS
- 7 BOCEPREVIR IN ADDITION TO STANDARD OF CARE ENHANCED SVR IN HEPATITIS C VIRUS (HCV) GENOTYPE-1 WITH ADVANCED FIBROSIS/CIRRHOSIS: SUBGROUP ANALYSIS OF SPRINT-2 AND RESPOND-2 STUDIES
- (2011) S. Bruno et al. JOURNAL OF HEPATOLOGY
- PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus
- (2011) Natalie Bzowej et al. LIVER TRANSPLANTATION
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study
- (2010) Savino Bruno et al. HEPATOLOGY
- Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing
- (2010) Wendy S.C. Cheng et al. JOURNAL OF HEPATOLOGY
- Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients
- (2009) A. IACOBELLIS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
- (2009) Maria Grazia Rumi et al. GASTROENTEROLOGY
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension
- (2009) E. G. Giannini et al. JOURNAL OF INTERNAL MEDICINE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics
- (2008) F. TEKIN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
- (2008) Jose A. Carrión et al. JOURNAL OF HEPATOLOGY
- Treatment of Chronic Hepatitis C Virus Infection With Pegylated Interferon and Ribavirin in Cirrhotic Patients Awaiting Liver Transplantation
- (2008) B.E. Annicchiarico et al. TRANSPLANTATION PROCEEDINGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now